Jeremy Robinson has extensive experience in securities and civil litigation. Since joining BLB&G, Jeremy has been involved in prosecuting many high-profile securities cases.
For example, he was an integral member of the teams that prosecuted In re Refco Securities Litigation (total recoveries in excess of $425 million); In re WellCare Health Plans, Inc. Securities Litigation ($200 million settlement, representing the second largest settlement of a securities case in Eleventh Circuit history); and In re Citigroup, Inc. Bond Action Litigation, which settled for $730 million, representing the second largest recovery ever in a securities class action brought on behalf of purchasers of debt securities and ranking among the fifteen largest recoveries in the history of securities class actions. He also recently represented investors in In re Bank of New York Mellon Corp. Forex Transactions Litigation, which settled for $180 million, In re Freeport-McMoRan Derivative Litigation, which settled for a cash recovery of nearly $154 million plus corporate governance reforms, and In re Allergan Proxy Violation Securities Litigation, which settled on the eve of trial for $250 million. The cases that Jeremy is presently prosecuting include In re Symantec Securities Litigation, Lord Abbett Affiliated Funds Inc. v. Navient Corporation et al., and In re Facebook Securities Litigation.
In 2000-01, Jeremy received the Harold G. Fox Scholarship and spent a year working with barristers and judges in London, England. In 2005, Jeremy obtained his Master of Laws degree from Columbia Law School, where he was honored as a Harlan Fiske Stone Scholar. Jeremy has also repeatedly been recognized as a leading practitioner by Lawdragon, Thomson Reuters’ Super Lawyers, and was recently named a "Litigation Star" by Benchmark Litigation.